10.1002/ejoc.201801604
European Journal of Organic Chemistry
FULL PAPER
(15.85 mmol, 1.3 equiv.) of n-butyllithium (2.5 M solution in hexane) were
added to the previous solution. Stirring was continued for 30 min at 0 °C
and the resulting LDA solution was then added dropwise into a 200-mL
Schlenk tube cooled to –80 °C containing 3.60 g (12.20 mmol) of -
aminonitrile (+)-4 dissolved in 50 mL of dry THF. The solution was warmed
to 0 °C and stirring was continued at that temperature for 12 h. The
solvents were evaporated under reduced pressure, and the crude material
was taken-up with 20 mL of water. The aqueous layer was extracted with
50 mL of diethyl ether (x 2) and the organic phases were dried over MgSO4
and concentrated. The crude oily residue is poured into a chromatography
column containing 40 g of silica and 1:2 petroleum ether/diethyl ether. The
fractions were collected and concentrated to afford 3.24 g (90%) of
enaminonitrile (–)-5 as a single diastereoisomer. Vitreous solid. Rf = 0.30
(petroleum ether/diethyl ether, 7:3). []22D = –200.7 (c 0.9, CHCl3).1H NMR
(CDCl3, 400 MHz) = 1.36 (d, J = 6.8 Hz, 3 H), 1.39–1.85 (m, 10 H), 2.10–
2.28 (m, 2 H), 2.37 (td, J = 11.8, 2.8 Hz, 1 H), 3.20 (dm, J = 11.8 Hz, 1 H),
3.83 (q, J = 6.8 Hz, 1 H), 5.01 (s, 2 H), 7.20–7.31 (m, 5 H). 13C NMR (CDCl3,
100 MHz) = 19.8 (s), 20.0 (s), 21.9 (p), 22.8 (s), 24.4 (s), 26.7 (s), 35.3
(s), 42.0 (s), 59.6 (t), 61.1 (q), 74.8 (q), 121.1 (q), 126.9 (t), 128.2 (t), 128.8
(t), 148.8 (q), 162.3 (q). IR (film, cm–1): 3468, 3361, 2930, 2181, 1615,
1573. HRMS (ESI+, CH3OH, C19H25N3Na [M + Na]+) calcd for 318.1946,
found 318.1944. Anal. Calcd for C19H25N3 (295.4): C, 77.25; H, 8.53; N,
14.22. Found C, 77.00; H, 8.55; N, 14.17.
4.0 Hz, 1 H), 2.10–2.31 (m, 1 H), 2.69 (dd, J = 10.4, 4.4 Hz, 1 H), 2.82 (dm,
J = 14.5 Hz, 1 H), 3.28 (ddd, J = 14.5, 12.7, 3.2 Hz, 1 H), 4.10 (q, J = 6.8
Hz, 1 H), 6.10 (dd, J = 4.8, 3.2 Hz, 1 H), 7.09 (d, J = 8.0 Hz, 1 H), 7.11–
7.20 (m, 2 H), 7.32 (dd, J = 7.3, 1.2 Hz, 1 H). 13C NMR (CDCl3, 100 MHz)
= 18.1 (s), 19.2 (s), 19.6 (s), 26.06 (p), 26.09 (s), 27.8 (s), 32.1 (s), 44.2
(s), 53.2 (t), 53.9 (q), 125.2 (t), 125.0 (t), 126.0 (t), 126.3 (t), 126.5 (t),133.3
(q), 138.9 (q), 139.0 (q). HRMS (ESI+, CH3OH, C18H24N [M + H]+) calcd for
254.1908, found 254.1910. Anal. Calcd for C18H23N (253.4): C, 85.32; H,
9.15; N, 5.53. Found C, 85.46; H, 9.13; N, 5.55.
(S)-1-azaspiro[5.5]undecan-7-one•(R)-mandelic acid, (–)-8. A 100-mL
low-pressure hydrogenator was charged with 60 mL of methanol, 3.0 g
(11.05 mmol) of spiropiperidine (+)-6 and 0.3 g (10% in mass) of 10% Pd/C.
Air was removed from the reactor by alternately venting it three times with
argon and filling it with hydrogen. The pressure (7.5 × 102 Torr, 1 bar) was
applied, and the solution was stirred for 24 h at room temperature. The
suspension was filtered over a short pad of Celite and the vessel was
washed with methanol. Then, 1.68 g (11.04 mmol) of (R)-(–)-mandelic acid
were added to the methanolic solution which was concentrated on a rotary
evaporator to afford 3.34 g (95%) of mandelate salt (–)-8 as a white solid.
Mp: 141–142 °C. []22D = –13.4 (c 1.0, CHCl3). 1H NMR (CDCl3, 400 MHz)
= 1.20–1.31 (m, 1 H), 1.48–1.71 (m, 7 H), 1.76 (td, J = 12.4, 4.4 Hz, 1 H),
1.86–1.95 (m, 1 H), 1.96–2.03 (m, 1 H), 2.12 (dm, J = 12.8 Hz, 1 H), 2.35–
2.45 (m, 2 H), 2.87–3.01 (m, 1 H), 3.30–3.40 (m, 1 H), 4.91 (s, 1 H), 7.19
(tt, J = 6.4, 1.0 Hz, 1 H), 7.24–7.30 (m, 3 H), 7.48 (d, J = 7.0 Hz, 2 H), 6.5–
8.5 (s, br. 2 H). 13C NMR (CDCl3, 400 MHz) = 18.6 (s), 20.6 (s), 21.7 (s),
27.3 (s), 29.1 (s), 35.3 (s), 38.2 (s), 40.6 (s), 65.3 (q), 74.2 (t), 126.6 (t),
126.8 (t), 127.8 (t), 142.4 (q), 177.7 (q), 207.9 (q). IR (neat, cm–1): 3157,
3060, 1724, 1606, 1584, 724. HRMS (ESI+, CH3OH, C10H18NO [M]+) calcd
for 168.1388, found 168.1388. Anal. C18H24NO4 (319.4): C, 67.69; H, 7.89;
N, 4.39. Found C, 67.94; H, 7.90; N, 4.33.
(S)-1-((1S)-1-phenylethyl-1-azaspiro[5.5]undecan-7-one, (+)-6. To
a
solution of enaminonitrile (–)-5 (4.00 g, 13.54 mmol) in toluene (60 mL)
were added 10 ml of 37% hydrochloric acid. The resulting biphasic system
was refluxed for 15 h and was poured onto a 10% Na2CO3 solution (150
mL). The solution was stirred for 1 h while maintaining the pH of the
aqueous phase at 12. The organic phase was discarded and the aqueous
layer was extracted with 50 mL of diethyl ether (x 2). The combined organic
phases (toluene plus diethyl ether) were washed with water, dried over
MgSO4 and concentrated. The crude oil was poured on a chromatography
column containing 40 g of a slurry of silica gel and 7:3 pentane/diethyl
ether. The combined fractions were concentrated to give 3.30 g (90%) of
spiropiperidine (+)-6. Colorless oil. Rf = 0.30 (petroleum ether/diethyl ether,
(S)-1-benzyl-1-azaspiro[5.5]undecan-7-one, (+)-9. To
a solution of
mandelate salt (–)-8 (0.32 g, 1.0 mmol) in DMSO (3 mL) were successively
added 0.150 g (1.41 mmol, 1.40 equiv.) of Na2CO3 and 0.342 g (2.0 mmol,
2.0 equiv.) of benzyl bromide. The reaction mixture was stirred at room
temperature for 72 h and was poured onto 50 ml of water. The products
were extracted with 150 mL diethyl ether (x 2) and the combined organic
phases were washed with water, dried over MgSO4 and concentrated. The
crude reaction mixture was poured on a chromatography column prepared
with 20 g of silica and 6:4 petroleum ether/diethyl ether. The combined
fractions were concentrated to afford 0.220 g (85%) of piperidine (+)-9.
1
7:3). []22D = +47.3 (c 1.0, CHCl3). H NMR (CDCl3, 400 MHz) = 1.18–
1.29 (m, 1 H), 1.36–1.50 (m, 1 H), 1.49 (d, J = 6.8 Hz, 3 H), 1.51–1.80 (m,
7 H), 1.90–2.00 (m, 1 H), 2.06 (ddd, J = 16.3, 11.9, 4.3 Hz, 1 H), 2.24 (dm,
J = 13.1 Hz, 1 H), 2.36 (dm, J = 14.5 Hz, 1 H), 2.44 (ddd, J = 18.5, 14.5,
6.3 Hz, 1 H), 2.71 (dt, J = 11.9, 4.4 Hz, 1 H), 3.21 (ddd, J = 11.9, 10.6, 3.4
Hz, 1 H), 4.15 (q, J = 6.8 Hz, 1 H), 7.14 (t, J = 7.2, Hz, 1 H), 7.27 (t, J = 7.8
Hz, 2 H), 7.37 (dm, J = 7.2 Hz, 2 H). 13C NMR (CDCl3, 100 MHz) = 20.1
(p), 20.9 (s), 21.6 (s), 26.3 (s), 27.1 (s), 35.7 (s), 37.8 (s), 40.5 (s), 43.2 (s),
56.5 (t), 69.3 (q), 125.8 (t), 126.8 (t), 128.0 (t), 148.6 (q), 216.2 (q). IR (film,
cm–1): 2928, 2858, 1705, 1445. HRMS (ESI+, CH3OH, C18H26NO [M + H]+)
calcd for 272.2014, found 272.2010. Anal. Calcd for C18H25NO (271.4): C,
79.66; H, 9.28; N, 5.16. Found C, 79.70; H, 9.24; N, 5.13.
Colorless oil. Rf = 0.30 (petroleum ether/diethyl ether, 60:40). []22 = +
D
1
15.0 (c 1.0, CHCl3). H NMR (CDCl3, 400 MHz) = 1.42–1.49 (m, 2 H),
1.51–1.74 (m, 5 H), 1.84–1.91 (m, 2 H), 1.92–2.03 (m, 2 H), 2.23 (ddd, J
= 12.9, 9.0, 3.4 Hz, 1 H), 2.36 (dt, J = 13.7, 7.1 Hz, 1 H), 2.62–2.80 (m, 2
H), 2.77 (dt, J = 13.7, 6.8 Hz, 1 H); 3.60 (d, J = 14.5 Hz, 1 H), 3.85 (d, J =
14.5 Hz, 1 H), 7.24 (tt, J = 7.2, 1.0 Hz, 1 H), 7.33 (t, J = 7.8 Hz, 2 H), 7.43
(dm, J = 7.2 Hz, 2 H). 13C NMR (CDCl3, 100 MHz) = 20.4 (s), 20.9 (s),
21.9 (s), 28.1 (s), 30.1 (s), 36.0 (s), 39.5 (s), 45.9 (s), 52.7 (s), 68.3 (q),
126.6 (t), 128.1 (t), 128.2 (t), 140.8 (q), 215.9 (q). IR (film, cm–1): 2939,
1732, 1494.8, 1447, 740, 699.0. HRMS (ESI+, CH3OH, C17H24NO [M + H]+)
calcd for 258.1858, found 258.1858. Anal. Calcd for C17H23NO (257.4): C,
79.33; H, 9.01; N, 5.44. Found C, 79.25; H, 8.95; N, 5.40.
(4aS,10S)-10-methyl-2,3,4,5,6,7,8,10-octahydropyrido[2,1-
e]phenanthridine, (–)-7. To a solution of spiropiperidine (+)-6 (0.50 g, 1.84
mmol) in toluene (20 mL) were added 2 ml of 37% HCl. The resulting
biphasic system was refluxed for 15 h and poured onto a 10% Na2CO3
solution (50 ml) while maintaining the pH of the aqueous phase at 12. The
organic phase was separated, and the aqueous layer was extracted with
50 mL of diethyl ether (x 2). The combined organic phases (toluene plus
diethyl ether) were washed with water, dried over MgSO4 and
concentrated. The crude oil was poured on a chromatography column
containing 10 g of silica and 7:3 of dichloromethane/ methanol. Unreacted
piperidine (+)-6 (0.35 g) was eluted first, followed by the more polar
hexahydrophenanthridine (–)-7 (0.14 g, 30%). Colorless oil. Rf = 0.30
(dichloromethane/methanol, 7:3). []22D = –159.3 (c 1.37, CHCl3). 1H NMR
(CDCl3, 400 MHz) = 1.17–1.25 (m, 1 H), 1.32 (d, J = 6.8 Hz, 3 H), 1.33–
1.37 (m, 2 H), 1.43–1.58 (m, 3 H), 1.66–1.85 (m, 3 H), 2.14 (dt, J = 17.0,
tert-Butyl-(S)-7-oxo-1-azaspiro[5.5]undecane-1-carboxylate, (+)-10. To a
suspension of mandelate salt (–)-8 (0.40 g, 1.25 mmol) in acetonitrile (25
mL) were successively added 0.273 g (1.23 mmol, 1.0 equiv.) of Boc2O
and 0.88 mL (0.65 g, 5.05 mmol, 4.04 equiv.) of DIPEA. The reaction
mixture was refluxed for 3 h and was poured onto 50 ml of brine. The
products were extracted with 50 mL diethyl ether (x 2) and the combined
organic phases were washed with water, dried over MgSO4 and
concentrated. The crude reaction mixture was poured on
a
chromatography column prepared with 20 of silica and 4:1
g
This article is protected by copyright. All rights reserved.